Felodipine

Product NDC
0378-5013
11-digit product format
003785013
Labeler code
0378
Product ID
0378-5013_2727fa5d-7ba0-4fd4-a1f3-cd6a7108e5bc
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Felodipine
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
Mylan Pharmaceuticals Inc.
Application
ANDA078855
Marketing category
ANDA
Marketing start
2008-04-18
Marketing end
2019-10-31
Substance
FELODIPINE
Active strength
10 mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct0378-5013DDiscontinued by firm2026-08-17
excluded packagepackage0378-50130378-5013-01DDiscontinued by firm2026-08-17
excluded packagepackage0378-50130378-5013-05DDiscontinued by firm2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0378-5013-05d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0378-5013-01d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0378-5013-05f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0378-5013-01f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0378-5013-052ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0378-5013-012ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0378-5013-05a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0378-5013-01a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0378-5013-05cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0378-5013-01cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0378-5013-05cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0378-5013-01cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage0378-5013-05302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage0378-5013-01302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage0378-5013-05ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage0378-5013-01ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage0378-5013-050efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage0378-5013-010efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage0378-5013-05ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage0378-5013-01ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage0378-5013-05367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage0378-5013-01367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage0378-5013-05557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage0378-5013-01557ba5c1ecfa…9c80585c8c6e…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A078855-001FELODIPINEFELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17
A078855-002FELODIPINEFELODIPINE5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17
A078855-003FELODIPINEFELODIPINE10MGTABLET, EXTENDED RELEASE / ORAL2008-04-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A078855-001FELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17caaa826d4ba7…
2026-08-18 06:07:402026-07A078855-002FELODIPINE5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17caaa826d4ba7…
2026-08-18 06:07:402026-07A078855-003FELODIPINE10MGTABLET, EXTENDED RELEASE / ORAL2008-04-17caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A078855-001FELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02A078855-002FELODIPINE5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02A078855-003FELODIPINE10MGTABLET, EXTENDED RELEASE / ORAL2008-04-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078855-001FELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078855-002FELODIPINE5MGTABLET, EXTENDED RELEASE / ORAL2008-04-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A078855-003FELODIPINE10MGTABLET, EXTENDED RELEASE / ORAL2008-04-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08A078855-001FELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08A078855-002FELODIPINE5MGTABLET, EXTENDED RELEASE / ORAL2008-04-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08A078855-003FELODIPINE10MGTABLET, EXTENDED RELEASE / ORAL2008-04-176a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078855-001FELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078855-002FELODIPINE5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A078855-003FELODIPINE10MGTABLET, EXTENDED RELEASE / ORAL2008-04-17fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078855-001FELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078855-002FELODIPINE5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A078855-003FELODIPINE10MGTABLET, EXTENDED RELEASE / ORAL2008-04-17b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078855-001FELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-1703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078855-002FELODIPINE5MGTABLET, EXTENDED RELEASE / ORAL2008-04-1703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A078855-003FELODIPINE10MGTABLET, EXTENDED RELEASE / ORAL2008-04-1703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078855-001FELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-172680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078855-002FELODIPINE5MGTABLET, EXTENDED RELEASE / ORAL2008-04-172680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A078855-003FELODIPINE10MGTABLET, EXTENDED RELEASE / ORAL2008-04-172680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078855-001FELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-175bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078855-002FELODIPINE5MGTABLET, EXTENDED RELEASE / ORAL2008-04-175bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A078855-003FELODIPINE10MGTABLET, EXTENDED RELEASE / ORAL2008-04-175bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078855-001FELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078855-002FELODIPINE5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A078855-003FELODIPINE10MGTABLET, EXTENDED RELEASE / ORAL2008-04-17d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A078855-001FELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17d06236e962d9…
2024-10-29 15:01 UTC2024-10A078855-002FELODIPINE5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17d06236e962d9…
2024-10-29 15:01 UTC2024-10A078855-003FELODIPINE10MGTABLET, EXTENDED RELEASE / ORAL2008-04-17d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078855-001FELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-1779d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078855-002FELODIPINE5MGTABLET, EXTENDED RELEASE / ORAL2008-04-1779d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A078855-003FELODIPINE10MGTABLET, EXTENDED RELEASE / ORAL2008-04-1779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078855-001FELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078855-002FELODIPINE5MGTABLET, EXTENDED RELEASE / ORAL2008-04-17301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A078855-003FELODIPINE10MGTABLET, EXTENDED RELEASE / ORAL2008-04-17301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A078855-001FELODIPINE2.5MGTABLET, EXTENDED RELEASE / ORAL2008-04-171e350fbaab3a…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2019-09-15 20:21 UTC2019-09A078855-001AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09A078855-002AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09A078855-003AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A078855-001AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07A078855-002AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07A078855-003AB1ea99ee380514…

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0378-5013-01EA - Each0378-50136a3103eb-3b04-4b70-b52f-b04a3ec5f38f12012-07-24
0378-5013-05EA - Each0378-50133891f42f-f201-41ef-ae27-1560bc8cd3f112012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
FELODIPINEACTIVE INGREDIENTOL961R6O2CFELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2
FELODIPINEACTIVE MOIETYOL961R6O2CFELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2
BUTYLATED HYDROXYANISOLEINACTIVE INGREDIENTREK4960K2UFELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171KFELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UFELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GFELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKFELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOFELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2
POLYDEXTROSEINACTIVE INGREDIENTVH2XOU12IEFELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1AFELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2
POVIDONESINACTIVE INGREDIENTFZ989GH94EFELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4FELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIFELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPFELODIPINE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]2